Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade

June 29, 2012 9:48 AM EDT Send to a Friend
Investors just can't get enough Orexigen Therapeutics (Nasdaq: OREX) following the FDA decision on Arena Pharmaceutircals (Nasdaq: ARNA) lorcaserin Wednesday and JPMorgan upgrade Thursday. Shares are up an additional 7.6 percent Friday, pushing shares up about 90 percent for the month of June.

Stock volatility is up about 2 percent from Thursday's close.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Momentum Movers

Related Entities

JPMorgan

Add Your Comment